{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:34:51Z","timestamp":1780565691213,"version":"3.54.1"},"reference-count":67,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[1999,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>There is an urgent need for effective vaccines against serogroup B<jats:italic>Neisseria meningitidis<\/jats:italic>. Current experimental vaccines based on the outer membrane proteins (OMPs) of this organism provide a measure of protection in older children but have been ineffective in infants. We postulated that the inability of OMP vaccines to protect infants might be due to age-dependent defects in cellular immunity. We measured proliferation and in vitro production of gamma interferon (IFN-\u03b3), tumor necrosis factor alpha, and interleukin-10 (IL-10) in response to meningococcal antigens by peripheral blood mononuclear cells (PBMCs) from children convalescing from meningococcal disease and from controls. After meningococcal infection, the balance of cytokine production by PBMCs from the youngest children was skewed towards a T<jats:sub>H<\/jats:sub>1 response (low IL-10\/IFN-\u03b3 ratio), while older children produced more T<jats:sub>H<\/jats:sub>2 cytokine (higher IL-10\/IFN-\u03b3 ratio). There was a trend to higher proliferative responses by PBMCs from older children. These responses were not influenced by the presence or subtype of class 1 (PorA) OMP or by the presence of class 2\/3 (PorB) or class 4 OMP. Even young infants might be expected to develop adequate cellular immune responses to serogroup B<jats:italic>N. meningitidis<\/jats:italic>vaccines if a vaccine preparation can be formulated to mimic the immune stimulus of invasive disease, which may include stimulation of T<jats:sub>H<\/jats:sub>2 cytokine production.<\/jats:p>","DOI":"10.1128\/iai.67.5.2452-2463.1999","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T15:34:52Z","timestamp":1577806492000},"page":"2452-2463","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":32,"title":["Cellular Immune Responses to<i>Neisseria meningitidis<\/i>in Children"],"prefix":"10.1128","volume":"67","author":[{"given":"Andrew J.","family":"Pollard","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Departments of Paediatrics and Infectious Diseases &amp; Microbiology, Imperial College School of Medicine, St. Mary\u2019s Hospital, London W2 1PG, United Kingdom,1and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Galassini","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Paediatrics and Infectious Diseases &amp; Microbiology, Imperial College School of Medicine, St. Mary\u2019s Hospital, London W2 1PG, United Kingdom,1and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileene M.","family":"Rouppe van der Voort","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Laboratory of Vaccine Development and Immune Mechanisms, National Institute of Public Health and the Environment, Bilthoven, The Netherlands2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hibberd","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Paediatrics and Infectious Diseases &amp; Microbiology, Imperial College School of Medicine, St. Mary\u2019s Hospital, London W2 1PG, United Kingdom,1and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Booy","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Paediatrics and Infectious Diseases &amp; Microbiology, Imperial College School of Medicine, St. Mary\u2019s Hospital, London W2 1PG, United Kingdom,1and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Langford","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Paediatrics and Infectious Diseases &amp; Microbiology, Imperial College School of Medicine, St. Mary\u2019s Hospital, London W2 1PG, United Kingdom,1and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Nadel","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Paediatrics and Infectious Diseases &amp; Microbiology, Imperial College School of Medicine, St. Mary\u2019s Hospital, London W2 1PG, United Kingdom,1and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ison","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Paediatrics and Infectious Diseases &amp; Microbiology, Imperial College School of Medicine, St. Mary\u2019s Hospital, London W2 1PG, United Kingdom,1and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Simon","family":"Kroll","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Paediatrics and Infectious Diseases &amp; Microbiology, Imperial College School of Medicine, St. Mary\u2019s Hospital, London W2 1PG, United Kingdom,1and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Poolman","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Laboratory of Vaccine Development and Immune Mechanisms, National Institute of Public Health and the Environment, Bilthoven, The Netherlands2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levin","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Paediatrics and Infectious Diseases &amp; Microbiology, Imperial College School of Medicine, St. Mary\u2019s Hospital, London W2 1PG, United Kingdom,1and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/383787a0"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0882-4010(88)90045-9"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.1987.tb02626.x"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-44-4-237"},{"key":"e_1_3_2_6_2","unstructured":"Anonymous 1995 communicable disease statistics vol. 22. Office of National Statistics 1997 HMSO Books London United Kingdom"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1996.497560.x"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91961-S"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)00037-N"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.2.757"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/165.5.813"},{"key":"e_1_3_2_13_2","first-page":"17","article-title":"Notifications of infectious diseases","volume":"8","author":"CDSC (Communicable Disease Surveillance Centre)","year":"1998","unstructured":"CDSC (Communicable Disease Surveillance Centre) Notifications of infectious diseases.Communicable Dis. Rep.819981720","journal-title":"Communicable Dis. Rep."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199609000-00018"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(96)00020-5"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)93086-3"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.4049\/jimmunol.154.4.1560","article-title":"Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns","volume":"154","author":"Durandy A.","year":"1995","unstructured":"Durandy A. De Saint Basile G. Lisowska-Grospierre B. Gauchat J. F. Forveille M. Kroczek R. A. Bonnefoy J. Y. Fischer A. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns.J. Immunol.154199515601568","journal-title":"J. Immunol."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.173.1.25"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.6.1360"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.2.Suppl.S134"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.37.1.155-159.1982"},{"key":"e_1_3_2_22_2","first-page":"67","article-title":"Production, characterization and control of MenB-vaccine \u201cFolkehelsa\u201d: an outer membrane vesicle vaccine against group B meningococcal disease","volume":"14","author":"Fredriksen J. H.","year":"1991","unstructured":"Fredriksen J. H. Rosenqvist E. Wedege E. Bryn K. Bjune G. Froholm L. O. Lindbak A. K. Mogster B. Namork E. Rye U. Production, characterization and control of MenB-vaccine \u201cFolkehelsa\u201d: an outer membrane vesicle vaccine against group B meningococcal disease.NIPH Ann.1419916779, 79\u201380.","journal-title":"NIPH Ann."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(87)80353-0"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830240832"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/135.1.94"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(95)70546-5"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1996.476587.x"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-198901000-00003"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4049\/jimmunol.126.1.50","article-title":"Newborn T cell suppression: early appearance, maintenance in culture, and lack of growth factor suppression","volume":"126","author":"Hayward A. R.","year":"1981","unstructured":"Hayward A. R. Kurnick J. Newborn T cell suppression: early appearance, maintenance in culture, and lack of growth factor suppression.J. Immunol.12619815053","journal-title":"J. Immunol."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1650688"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.9.2.186-188.1979"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.4049\/jimmunol.153.11.4948","article-title":"Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2","volume":"153","author":"Kawano Y.","year":"1994","unstructured":"Kawano Y. Noma T. Yata J. Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2.J. Immunol.153199449484958","journal-title":"J. Immunol."},{"key":"e_1_3_2_33_2","first-page":"149","article-title":"Cytokines, immunoglobulins, and IgG subclasses in patients with IgG plasmacytomas","volume":"22","author":"Klouche M.","year":"1994","unstructured":"Klouche M. Wilhelm D. Kirchner H. Cytokines, immunoglobulins, and IgG subclasses in patients with IgG plasmacytomas.Immun. Infekt.221994149151","journal-title":"Immun. Infekt."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.24.9743"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114970"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03530430043037"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.56.12.3221-3227.1988"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199708000-00018"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830240524"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.171.6.1871"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91297-8"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.3.959-965.1998"},{"key":"e_1_3_2_43_2","unstructured":"Noah N. Connolly M. Surveillance of bacterial meningitis in Europe 1995. 1996 King\u2019s European Meningitis Surveillance Unit London United Kingdom"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(96)00001-1"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.9.3897-3903.1992"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.77.6.542"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-198811000-00006"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.5.2441-2451.1999"},{"key":"e_1_3_2_49_2","first-page":"R49","article-title":"Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales","volume":"7","author":"Ramsay M.","year":"1997","unstructured":"Ramsay M. Kaczmarski E. Rush M. Mallard R. Farrington P. White J. Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales.Communicable Dis. Rep. Rev.71997R49R54","journal-title":"Communicable Dis. Rep. Rev."},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.7.2745-2751.1996"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.12.5184-5190.1997"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1998.00401.x"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117469"},{"key":"e_1_3_2_54_2","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra G. V.","year":"1991","unstructured":"Sierra G. V. Campa H. C. Varcacel N. M. Garcia I. L. Izquierdo P. L. Sotolongo P. F. Casanueva G. V. Rico C. O. Rodriguez C. R. Terry M. H. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba.NIPH Ann.141991195207, 208\u2013210.","journal-title":"NIPH Ann."},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115400"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/155.1.28"},{"key":"e_1_3_2_57_2","unstructured":"Tappero J. Lagos R. Maldonado A. Herrera P. Gheesling L. Williams D. Carlone G. Plikaytis B. Nokleby H. Holst J. Sierra G. Perkins B. Serum bactericidal activity elicited by two outer membrane protein serogroup B meningococcal vaccines among infants pre-school children and adults in Santiago Chile. 1996 Neisseria \u201996 110th International Pathogenic Neisseria Conference Baltimore Md"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.58.5.1355-1359.1990"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.3.632"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.8.3156-3161.1992"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1994.tb44295.x"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.3.1151"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.1.298-304.1996"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.176.1.79"},{"key":"e_1_3_2_65_2","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.4049\/jimmunol.147.6.2012","article-title":"T cell recognition of Neisseria meningitidis class 1 outer membrane proteins. Identification of T cell epitopes with selected synthetic peptides and determination of HLA restriction elements","volume":"147","author":"Wiertz E. J.","year":"1991","unstructured":"Wiertz E. J. van Gaans-van den Brink J. A. Schreuder G. M. Termijtelen A. A. Hoogerhout P. Poolman J. T. T cell recognition of Neisseria meningitidis class 1 outer membrane proteins. Identification of T cell epitopes with selected synthetic peptides and determination of HLA restriction elements.J. Immunol.147199120122018","journal-title":"J. Immunol."},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)82182-1"},{"key":"e_1_3_2_67_2","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.4049\/jimmunol.151.4.1938","article-title":"IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells","volume":"151","author":"Wu C. Y.","year":"1993","unstructured":"Wu C. Y. Demeure C. Kiniwa M. Gately M. Delespesse G. IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells.J. Immunol.151199319381949","journal-title":"J. Immunol."},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109383"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.67.5.2452-2463.1999","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.67.5.2452-2463.1999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T14:38:42Z","timestamp":1695566322000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.67.5.2452-2463.1999"}},"subtitle":[],"editor":[{"given":"R. N.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["10.1128\/IAI.67.5.2452-2463.1999"],"URL":"https:\/\/doi.org\/10.1128\/iai.67.5.2452-2463.1999","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,5]]},"assertion":[{"value":"1998-09-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-02-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}